SanBio Company Limited announced consolidated earnings results for Fiscal Year Ended January 31, 2019. For the period, the company reported operating revenue of ¥741 million, operating loss of ¥3,733 million, ordinary loss of ¥2,919 million, loss attributable to owners of parent of ¥2,920 million or ¥60.17 per share, compared to the operating revenue of ¥490 million, operating loss of ¥4,378 million, ordinary loss of ¥3,947 million, loss attributable to owners of parent of ¥3,940 million or ¥86.85 per share for the same period a year ago.

The company provided earnings guidance for the first half of fiscal year 2020. The company forecast operating revenue of ¥284 million, operating loss of ¥3,445 million, ordinary loss of ¥3,196 million, loss attributable to owners of parent of ¥3,197 million or ¥64.29 diluted per share.

The company provided earnings guidance for the year ending January 31, 2020. The company forecast operating revenue of ¥713 million, operating loss of ¥5,887 million, ordinary loss of ¥5,390 million, loss attributable to owners of parent of ¥5,395 million or ¥108.48 diluted per share.